Tumor-bearing mice were given a single i.t. injection of mANK-101 alone or combined with PD-1 or CTLA-4 blockade starting either simultaneously (concurrent) or 1 week after (sequential) mANK-101 injection. The gene discussed is CTLA4; the disease is neoplasm.